Why do people vary in their responses to prescribed medications, both with respect to how well the drug works and in their adverse reactions to it? The answer may lie in our genes. Scientists, doctors, and the pharmaceutical industry are working to customize medical treatments to suit our genetic signatures. The study of how our genetic variations interface with disease risk and responses to drugs is called pharmacogenomics.
Supported by a Science Education Partnership Award (SEPA) Grant No. R25RR023288 from the National Center for Research
Resources, a component of the NIH. The contents provided here are solely the responsibility of the authors and do not necessarily
represent the official views of NIH.